All In MedTech

Device Trial Radar · NCT01978470

External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy

External Trigeminal Nerve Stimulation for Epilepsy

Last checked: Nov 20, 2026Latest source record: Apr 13, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

20

Planned (sponsor's estimate)

Start

Jun 2012

Primary completion

Jun 2016

Study completion Aug 2016

Sponsor

Lead sponsor
NeuroSigma, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Olive View-UCLA Education & Research Institute
First posted
Nov 7, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the tolerability and safety of the NeuroSigma eTNS system.

Conditions

  • Seizure Disorder

Interventions

  • External Trigeminal Nerve Stimulation (eTNS)Device

    External stimulation of the trigeminal nerve.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety of eTNSTime frame: Four weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Olive View/UCLA Medical Center

    Sylmar, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.